Clinical Trials Browser

Phase 1 × NIH × trebananib × Clear all

NCT01538095 2016-10-03

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors

Phase 1 Completed

Central Nervous System Neoplasms

NCT01548482 2015-10-06

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Phase 1 Completed

Carcinoma, Renal Cell